Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ross I Baker

Showing results (21-30 of 53) with videos related to

Pageof 6
Sort By:
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|October 2, 2007
C-reactive protein in ischemic stroke and its etiologic subtypesJohn W Eikelboom, Graeme J Hankey, Ross I Baker, et al.
British Journal of Haematology|February 13, 2010
Restored platelet function after romiplostim treatment in a patient with immune thrombocytopenic purpuraElizabeth E Gardiner, James Y Thom, Mohammad Al-Tamimi, et al.
Journal of Thrombosis and Haemostasis : JTH|October 18, 2021
Examining international practices in the management of pregnant women with von Willebrand diseaseMichelle Lavin, Analia Sánchez Luceros, Peter Kouides, et al.
Journal of Thrombosis and Haemostasis : JTH|February 24, 2023
Corrigendum to Examining international practices in the management of pregnant women with von Willebrand disease [J Thromb Haemost. 2022 Jan;20(1):82-91]Michelle Lavin, Analia Sánchez Luceros, Peter Kouides, et al.
The Medical Journal of Australia|October 20, 2009
A consensus statement on the management of pregnancy and delivery in women who are carriers of or have bleeding disordersScott M Dunkley, Susan J Russell, John A Rowell, et al.
Blood Research|November 16, 2019
Prognostic utility of ADAMTS13 activity for the atypical hemolytic uremic syndrome (aHUS) and comparison of complement serology between aHUS and thrombotic thrombocytopenic purpuraJisu Oh, Doyeun Oh, Seon Ju Lee, et al.
Journal of Thrombosis and Haemostasis : JTH|June 5, 2026
Management of Women with type 2B von Willebrand Disease During Pregnancy and Postpartum: Guidance from ISTH SSC Subcommittees on von Willebrand Factor and Women's Health Issues in Thrombosis and HaemostasisPredrag Miljic, Abdelrahman Noureldin, Analia Sanchez-Luceros, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|September 3, 2009
A novel ABCA1 nonsense mutation, R1270X, in Tangier disease associated with an unrecognised bleeding tendencyAmanda J Hooper, Ken Robertson, Lydia Ng, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 9, 2005
Randomized comparison of low molecular weight heparin and coumarin derivatives on the survival of patients with cancer and venous thromboembolismAgnes Y Y Lee, Frederick R Rickles, Jim A Julian, et al.
Thrombosis and Haemostasis|February 4, 2021
Estradiol-Responsive miR-365a-3p Interacts with Tissue Factor 3'UTR to Modulate Tissue Factor-Initiated Thrombin GenerationJiayin Tian, Murray J Adams, Jasmine Wee Ting Tay, et al.
Pageof 6

Showing results (21-30 of 53) with videos related to

Sort By:
Pageof 6
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|October 2, 2007
C-reactive protein in ischemic stroke and its etiologic subtypesJohn W Eikelboom, Graeme J Hankey, Ross I Baker, et al.
British Journal of Haematology|February 13, 2010
Restored platelet function after romiplostim treatment in a patient with immune thrombocytopenic purpuraElizabeth E Gardiner, James Y Thom, Mohammad Al-Tamimi, et al.
Journal of Thrombosis and Haemostasis : JTH|October 18, 2021
Examining international practices in the management of pregnant women with von Willebrand diseaseMichelle Lavin, Analia Sánchez Luceros, Peter Kouides, et al.
Journal of Thrombosis and Haemostasis : JTH|February 24, 2023
Corrigendum to Examining international practices in the management of pregnant women with von Willebrand disease [J Thromb Haemost. 2022 Jan;20(1):82-91]Michelle Lavin, Analia Sánchez Luceros, Peter Kouides, et al.
The Medical Journal of Australia|October 20, 2009
A consensus statement on the management of pregnancy and delivery in women who are carriers of or have bleeding disordersScott M Dunkley, Susan J Russell, John A Rowell, et al.
Blood Research|November 16, 2019
Prognostic utility of ADAMTS13 activity for the atypical hemolytic uremic syndrome (aHUS) and comparison of complement serology between aHUS and thrombotic thrombocytopenic purpuraJisu Oh, Doyeun Oh, Seon Ju Lee, et al.
Journal of Thrombosis and Haemostasis : JTH|June 5, 2026
Management of Women with type 2B von Willebrand Disease During Pregnancy and Postpartum: Guidance from ISTH SSC Subcommittees on von Willebrand Factor and Women's Health Issues in Thrombosis and HaemostasisPredrag Miljic, Abdelrahman Noureldin, Analia Sanchez-Luceros, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|September 3, 2009
A novel ABCA1 nonsense mutation, R1270X, in Tangier disease associated with an unrecognised bleeding tendencyAmanda J Hooper, Ken Robertson, Lydia Ng, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 9, 2005
Randomized comparison of low molecular weight heparin and coumarin derivatives on the survival of patients with cancer and venous thromboembolismAgnes Y Y Lee, Frederick R Rickles, Jim A Julian, et al.
Thrombosis and Haemostasis|February 4, 2021
Estradiol-Responsive miR-365a-3p Interacts with Tissue Factor 3'UTR to Modulate Tissue Factor-Initiated Thrombin GenerationJiayin Tian, Murray J Adams, Jasmine Wee Ting Tay, et al.
Pageof 6